{
  "ticker": "TRP",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968528",
  "id": "02968528",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250711",
  "time": "0957",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250711/pdf/06lq2mch66f570.pdf",
  "summary": "- **Distribution Agreements**:  \n  - Signed multi-year deal with Advanced Cosmeceuticals (Australia/NZ) for TR Pro+\u00ae, targeting 2,500+ clinics, major pharmacy chains (Chemist Warehouse, Priceline), and online retail.  \n  - First international distributor secured: Amellie and Proud (Thailand) for TR Pro+\u00ae launch.  \n\n- **Commercial Scale-Up**:  \n  - Transitioning to commercial-scale manufacturing; scaled production expected by late 2026.  \n  - TR Pro+\u00ae Australia-wide launch targeted for February 2026 (soft launch possible earlier).  \n\n- **Regulatory Progress**:  \n  - FDA 510(k), CE Mark, and TGA pathways underway for global expansion (9\u201312 month timeline).  \n  - TGA-listed medicine status already secured for medical/aesthetic use.  \n\n- **Market Validation**:  \n  - Strong demand in Australian pilot (stock shortages in July 2025).  \n  - Retained rights for medical/acute wound care line; dedicated launch planned.  \n\nNo capital raising or financial metrics disclosed. Focus on commercialization and expansion.",
  "usage": {
    "prompt_tokens": 1707,
    "completion_tokens": 233,
    "total_tokens": 1940,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-11T00:01:49.223978"
}